No obesity | Obesity | |||||||
---|---|---|---|---|---|---|---|---|
Total | Infection | No infection | P | Total | Infection | No infection | P | |
n = 216 | n = 104 | n = 112 | n = 163 | n = 76 | n = 87 | n = 163 | ||
Admission rate | 208 (96.3) | 98 (94.2) | 110 (98.2) | 0.158 | 158 (96.9) | 76 (100.0) | 82 (94.3) | 0.061 |
ICU admission rate | 23 (10.6) | 10 (8.9) | 13 (12.5) | 0.395 | 12 (7.4) | 6 (7.9) | 6 (6.9) | 0.808 |
Duration of steroid use, days | 10.4 ± 10.5 | 11.0 ± 13.1 | 9.9 ± 7.0 | 0.456 | 12.8 ± 12.6 | 12.7 ± 9.6 | 12.8 ± 14.8 | 0.983 |
Duration of exacerbation, days | 10.4 ± 8.4 | 11.2 ± 9.9 | 9.6 ± 6.4 | 0.173 | 11.7 ± 9.2 | 11.9 ± 8.1 | 11.5 ± 10.2 | 0.768 |
Total n = 216 | Bacterial infection n = 45 | No infection n = 171 | P | Total n = 163 | Bacterial infection n = 31 | No infection n = 132 | P | |
Duration of steroid use, days | 10.4 ± 10.5 | 13.6 ± 19.8 | 9.7 ± 6.7 | 0.049 | 12.8 ± 12.6 | 14.6 ± 8.8 | 12.3 ± 13.3 | 0.392 |
Duration of exacerbation, days | 10.4 ± 8.4 | 12.5 ± 10.0 | 9.9 ± 7.8 | 0.061 | 11.7 ± 9.2 | 12.0 ± 7.1 | 11.7 ± 9.7 | 0.868 |
Total n = 216 | Chlamydia infection n = 9 | No infection n = 207 | P | Total n = 163 | Chlamydia infection n = 1 | No infection n = 162 | P | |
Duration of steroid use, days | 10.4 ± 10.5 | 25.0 ± 39.2 | 9.8 ± 6.7 | < 0.001 | 12.8 ± 12.6 | 22 | 12.7 ± 12.6 | 0.463 |
Duration of exacerbation, days | 10.4 ± 8.4 | 22.7 ± 15.9 | 9.9 ± 7.5 | < 0.001 | 11.7 ± 9.2 | 7 | 11.7 ± 9.2 | 0.610 |